(Q38211078)

31 August 2017

The role of inflammation in bladder cancer (English)

1 reference

31 August 2017

0 references

Georgios Gakis

1

1 reference

PubMed ID

24818724

31 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Advances in Experimental Medicine and Biology

31 August 2017

1 reference

31 August 2017

816

1 reference

31 August 2017

183-196

1 reference

Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.

31 August 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Inflammation and cancer: back to Virchow?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Interferon-alpha inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Adenosine A2B receptor blockade slows growth of bladder and breast tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Loss of SPARC in bladder cancer enhances carcinogenesis and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Interactions between endothelial selectins and cancer cells regulate metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Can we still afford bladder cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Plasma C-reactive protein and risk of cancer: a prospective study from Greece.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

Versican: a versatile extracellular matrix proteoglycan in cell biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-0837-8_8

10.1007/978-3-0348-0837-8_8

31 March 2020

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24818724